Neutralizing Antibody Responses to SARS-COV-2 Infection vary by age, lymphocyte count, and CRP titer: MedRxiv

Coronavirus by Engin Akyurt via pixabay.com (open access)

A non-peer-reviewed study on the preprint server MedRxiv published March 30 examined a cohort of 175 patients who recovered from “mild” COVID-19 with blood tests for antibodies to SARS-COV-2.  They found widely varying levels of neutralizing antibody (specific antibodies for the virus) with a correlation between age and levels.  Older patients and those with higher levels of CRP (C-reactive protein, a measure of the severity of illness) had higher antibody levels (titers).  Ten patients had undetectable antibody– no antibody was found; two patients had extremely high titers of antibody.

It appears that patients with more severe illness developed higher antibody titers.  It is possible that the high levels of antibody may indicate more tissue damage from the infection.  The authors also speculate that recovered patients with high antibody titers would be useful for obtaining serum to use in treatment of acutely ill patients.